MedCap's financial development
MedCap seeks to provide accurate and timely information to the stock market and its stakeholders. The following pages contain financial reports, presentations, press releases and information about the company’s financial performance.
Please also refer to the “About MedCap” section to find out more about our mission, strategy and how we create value.
Interim report 3 2022
Interim report 2 2022
Interim report 4 2022
MedCap as an investment
MedCap acquires and develops profitable, market-leading niche companies in the life science industry in Northern Europe that have the potential to grow internationally. The group conducts operations in two areas: MedTech and Specialty Pharma.
The company complies with Nasdaq Stockholm’s rules for issuers and applies the Swedish Corporate Governance Code (the “Code”).